Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Canopy USA

Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results

Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) recently reported its financial results for the third quarter that ended September 30, 2022 (&ldquo

Acreage Holdings Q3 Financial Results, A "Highly Attractive Positioning"

Acreage Holdings Q3 Financial Results, A "Highly Attractive Positioning"

Acreage Holdings, Inc.(CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), reported its financial results late Monday for the third quarter ended September 30, 2022 (“Q3 2022”).

What Happens To Cannabis Bills If Republicans Take House And Senate? Here's One View

What Happens To Cannabis Bills If Republicans Take House And Senate? Here's One View

"The Risk of a Post-Election Funk”

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Forget About SAFE Plus Or CLIMB Act As Cannabis Stock Catalysts, With Canopy's Potential Exception

Canopy Growth Corporation (NASDAQ: CGC)

North American Cannabis Market: Is Interest Waning In Canada And The US? Here's What A New Report Says

As Benzinga recently reported, sales growth in Canada appears to be stagnating for the cannabis sector. According to Cantor Fitzgerald's Pablo Zuanic, the

Canopy Could End Up Delisted: NASDAQ Objects To Its Game Plan To Speed Up Entry Into US Cannabis Market

Canopy Growth’s (NASDAQ: CGC) (TSE: WEED) recently-announced plan to conquer t

Constellation Switches to Hands Off Approach With Canopy Growth

Constellation Brands still holds a big stake in Canopy Growth, but the beer and spirits maker is disentangling itself from the Canadian cannabis company.

inkl

Read news from The Economist, FT, and more,
with one subscription

This Is How It's Done: Why Is Canopy's US Consolidation Plan Blueprint For Other Canadian Cannabis LPs

This Is How It's Done: Why Is Canopy's US Consolidation Plan Blueprint For Other Canadian Cannabis LPs

Canadian cannabis giant Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) announced its intention to consolidate in the US via a new holding company dubbed Canopy

Canopy Growth Transfers Its TerrAscend Assets To Canopy USA Company

Canopy Growth Transfers Its TerrAscend Assets To Canopy USA Company

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) and Canopy USA, LLC announced that each of the company and Canopy USA has filed an early warning report under National Instrument 62-103 - The early warning system and related take-over bid

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Canopy's Shares Slightly Up On Plans To Conquer US Cannabis Market

Canopy's Shares Slightly Up On Plans To Conquer US Cannabis Market

Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) is creating a new U.S.-domiciled holding company, Canopy USA, LLC. Canopy USA will hold the company's U.S.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Constellation Brands

Canopy Growth Corporation

Tilray Brands Inc.

Astellas Pharma Inc

Canopy Growth Corp

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

165,826 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play